Ubs Group Ag Embecta Corp. Transaction History

Ubs Group Ag

$528 Billion
Q1 2025

A detailed history of Ubs Group Ag transactions in Embecta Corp. stock. As of the latest transaction made, Ubs Group Ag holds 385,409 shares of EMBC stock, worth $4.78 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

385,409

Previous 802,866 52.0%

Holding current value

$4.78 Million

Previous $16.7 Million 70.54%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$12.28 - $20.93 $5.13 Million - $8.74 Million	-417,457 Reduced 52.0%	385,409 $4.91 Million
Q4 2024 Feb 14, 2025	BUY	$12.51 - $20.83 $9.37 Million - $15.6 Million	749,363 Added 1400.6%	802,866 $16.7 Million
Q3 2024 Nov 14, 2024	BUY	$11.46 - $16.56 $379,165 - $547,904	33,086 Added 162.05%	53,503 $754,000
Q2 2024 Aug 13, 2024	SELL	$10.13 - $14.6 $433,695 - $625,069	-42,813 Reduced 67.71%	20,417 $255,000
Q1 2024 May 13, 2024	BUY	$12.35 - $19.33 $208,739 - $326,715	16,902 Added 36.48%	63,230 $839,000
Q4 2023 Feb 09, 2024	BUY	$12.87 - $19.09 $231,106 - $342,799	17,957 Added 63.29%	46,328 $876,000
Q3 2023 Nov 09, 2023	SELL	$15.0 - $22.17 $439,425 - $649,470	-29,295 Reduced 50.8%	28,371 $426,000
Q2 2023 Aug 11, 2023	BUY	$21.6 - $30.69 $311,407 - $442,457	14,417 Added 33.33%	57,666 $1.25 Million
Q1 2023 May 12, 2023	BUY	$23.07 - $32.77 $97,839 - $138,977	4,241 Added 10.87%	43,249 $1.22 Million
Q4 2022 Feb 08, 2023	BUY	$25.29 - $35.48 $278,190 - $390,279	11,000 Added 39.27%	39,008 $986,000
Q3 2022 Nov 10, 2022	SELL	$24.0 - $33.42 $98,928 - $137,757	-4,122 Reduced 12.83%	28,008 $806,000
Q2 2022 Aug 10, 2022	BUY	$24.78 - $33.36 $796,181 - $1.07 Million	32,130 New	32,130 $814,000

Others Institutions Holding EMBC

# of Institutions

415

Shares Held

56.3M

Call Options Held

54.8K

Put Options Held

32.3K

View Full List

About Embecta Corp.

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $718M
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

More about EMBC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account